Falcon Edge Capital 13F holdings, Q4 2015
Holdings as of December 31, 2015 · filings on SEC EDGAR · latest filing →
Falcon Edge Capital disclosed 20 US equity positions worth $1.5bn in its Q4 2015 13F filing. The largest position was LIBERTY INTERACTIVE CORP at 12.2% of the reported book, followed by ALLERGAN PLC and LNG. Against the Q3 2015 filing, it opened 5 new positions, added to 1 and reduced 2 among the top 20 holdings.
What did Falcon Edge Capital own in Q4 2015? Top 20 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2015 |
|---|---|---|---|---|---|---|---|
| 1 | LIBERTY INTERACTIVE CORP | 12.2% | $187.5m | 4,157,000 | 0% | held | |
| 2 | ALLERGAN PLC | 12.1% | $185.2m | 592,542 | 0% | held | |
| 3 | LNG CHENIERE ENERGY INC | Energy | 11.1% | $170.2m | 4,569,514 | 0% | held |
| 4 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 6.8% | $103.5m | 2,066,331 | 0% | held | |
| 5 | ALLE ALLEGION PUB LTD CO | Industrials | 6.6% | $101.4m | 1,538,344 | -18% | reduced |
| 6 | META FACEBOOK INC | Communication Services | 6.4% | $97.3m | 930,000 | 0% | held |
| 7 | JD JD COM INC | Consumer Cyclical | 5.9% | $89.9m | 2,786,000 | -10% | reduced |
| 8 | SIX FLAGS ENTMT CORP NEW | 5.4% | $83.1m | 1,513,038 | 22% | added | |
| 9 | CDK CDK GLOBAL INC | 5.1% | $78.1m | 1,644,741 | 0% | held | |
| 10 | AMZN AMAZON COM INC | Consumer Cyclical | 4.2% | $64.5m | 95,500 | – | new |
| 11 | PANDORA MEDIA INC | 4.1% | $62.6m | 4,670,900 | 0% | held | |
| 12 | KHC KRAFT HEINZ CO | Consumer Defensive | 3.7% | $57.3m | 788,000 | – | new |
| 13 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 3.0% | $46.3m | 491,713 | 0% | held |
| 14 | YUM YUM BRANDS INC | Consumer Cyclical | 2.9% | $43.9m | 601,000 | – | new |
| 15 | LIBERTY GLOBAL PLC | 2.7% | $42.1m | 979,000 | – | new | |
| 16 | MASONITE INTL CORP NEW | 2.4% | $37.2m | 608,000 | 0% | held | |
| 17 | NFLX NETFLIX INC | Communication Services | 1.9% | $29.2m | 255,000 | 0% | held |
| 18 | MEDICINES CO | 1.6% | $23.9m | 640,000 | – | new | |
| 19 | VALE VALE S A | 1.1% | $17.0m | 6,653,000 | 0% | held | |
| 20 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 0.8% | $11.7m | 2,618,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.